Abstract
Panelists: Dr Gerald A. Faich, Director, Office of Epidemiology, Food and Drug Administration, Rockville, Maryland; Dr Gottfried Kreutz, Bundesgesundheitsamt, Institut für Arzneimittel, Berlin, West Germany; Dr Bernard Begaud; Director, Centre de Pharmacy, Hospital Carreire/Pellegr, Bordeaux, France; Dr Graham Burton, Senior Medical Officer, DHSS, England; Dr Win M. Castle, ICI Pharmaceuticals, Cheshire, England; Dr Hugh H. Tilson, Head, Epidemiology, Information and Surveillance, Burroughs Wellcome, Research Triangle Park, North Carolina.
Get full access to this article
View all access options for this article.